Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognosis in pulmonary embolism.

J D Douketis1

  • 1Department of Medicine, St. Joseph's Hospital, McMaster University, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada. jdouket@mcmaster.ca

Current Opinion in Pulmonary Medicine
|October 5, 2001
PubMed
Summary

Pulmonary embolism (PE) prognosis varies widely. Identifying risk factors for recurrent PE, post-thrombotic syndrome, and chronic thromboembolic pulmonary hypertension is crucial for guiding treatment and patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more.

Thrombosis research·2020
Same author

Weight-adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm.

Journal of thrombosis and haemostasis : JTH·2017
Same author

To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: comment.

Journal of thrombosis and haemostasis : JTH·2016
Same author

D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment.

Thrombosis research·2016
Same author

Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.

Journal of thrombosis and haemostasis : JTH·2016

Area of Science:

  • Cardiology
  • Pulmonary Medicine
  • Vascular Medicine

Background:

  • Acute pulmonary embolism (PE) presents a broad spectrum of prognoses, from sudden death to a treatable condition.
  • Survivors of acute PE treated with antithrombotics face risks of recurrence, post-thrombotic syndrome, and chronic thromboembolic pulmonary hypertension (CTEPH).

Purpose of the Study:

  • To estimate the risks of adverse sequelae following treated pulmonary embolism.
  • To identify risk factors associated with these sequelae for improved clinical decision-making and patient counseling.

Main Methods:

  • This is a review article synthesizing existing data on pulmonary embolism outcomes.
  • The review focuses on estimating risks of recurrent venous thromboembolism, fatal PE, post-thrombotic syndrome, and CTEPH.

Related Experiment Videos

Main Results:

  • Estimates of the risks for recurrent nonfatal venous thromboembolism, fatal pulmonary embolism, post-thrombotic syndrome, and CTEPH are provided.
  • Key risk factors contributing to these adverse outcomes are identified.

Conclusions:

  • Accurate risk stratification is essential for tailoring antithrombotic therapy intensity and duration.
  • Understanding prognosis and risk factors aids clinicians in discussing outcomes with patients and optimizing surveillance strategies.